Clinical trials
ADHD clinical trials
Below are recruiting adhd clinical trials, each written for real people, not researchers. We’re tracking 151 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07182344Enrolling by invitation
Brain stimulation and attention control in kids with ADHD
This study tests whether a gentle brain stimulation technique called transcranial magnetic stimulation (TMS) can help children with ADHD improve their attention. If it works, it could offer a new non-medication option.
AlmatyAges 6–12 - NCT07087327RecruitingPhase 3
Long-term study of EB-1020 for children with ADHD
This trial tests a new medication, EB-1020, over a longer period in children with ADHD. It aims to see if the drug continues to be safe and effective beyond the initial 6-week treatment. Some participants may have already been in a previous EB-1020 study, while others are new.
SapporoAges 6–17 - NCT07086313RecruitingPhase 2/Phase 3
Testing a new ADHD drug for children
This trial tests an experimental drug (EB-1020) for children with ADHD. It aims to see if the drug is safe and effective in reducing ADHD symptoms.
SapporoAges 6–17 - NCT07037030Enrolling by invitation
Mindfulness for ADHD in children
This study tests a mindfulness program designed to help children ages 7 to 11 with ADHD improve focus and manage symptoms. It may be a good option if you're looking for a non-medication approach.
Brookline, MassachusettsAges 7–11 - NCT06931080RecruitingPhase 2/Phase 3
Study of EB-1020 for adults with ADHD
This trial tests a new medication called EB-1020 for adults with ADHD. It aims to see if the drug is safe and effective in improving ADHD symptoms. You may be able to join if you have a clear ADHD diagnosis and your symptoms are moderate to severe.
TokyoAges 18–55 - NCT06926829RecruitingPhase 3
Long-term study of EB-1020 for adults with ADHD
This trial is for adults with ADHD who completed a previous study of the drug EB-1020. It tests the long-term safety and effectiveness of the medication over an extended period.
TokyoAges 18–55 - NCT06604845Enrolling by invitation
ADHD group therapy: CBT vs. activity groups
This study compares two types of group therapy for adults with ADHD: one using cognitive behavioral therapy (CBT) and another involving structured activities. It aims to find which approach best helps with ADHD symptoms.
GothenburgAges 18 years+ - NCT06194162Recruiting
Weighted blankets for better sleep in kids with ADHD
This trial tests if weighted blankets can help children with ADHD who still have trouble sleeping after trying standard sleep tips. The study looks at whether these special blankets improve sleep and daily life.
FrederiksbergAges 5–12 - NCT06465641RecruitingPhase 4
Methylphenidate for ADHD symptoms in KBG syndrome
This study tests if the medication methylphenidate (commonly used for ADHD) can help manage attention and behavior problems in people with KBG syndrome. Each person acts as their own test case to see if the drug works for them.
Nijmegen, GelderlandAges 6–20 - NCT07755410RecruitingPhase 2
Investigational ADHD treatment for adults
This study tests an investigational medication for adults with attention deficit hyperactivity disorder (ADHD). It aims to see if this new drug helps reduce ADHD symptoms compared to a placebo.
Chino, CaliforniaAges 18–65 - NCT06073470Recruiting
Brain activity tests to predict ADHD medication response
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
TaipeiAges 6–18 - NCT03666416Recruiting
Exercise study for college students with ADHD symptoms
This study looks at what happens in the body and thinking after exercising in college students who have ADHD. It may help researchers understand how exercise affects attention and brain function in adults with ADHD.
Laramie, WyomingAges 18–29 - NCT03781765RecruitingPhase 4
Testing stimulant vs non-stimulant ADHD treatments in young kids
This study compares stimulant and non-stimulant ADHD medicines in kids who have not taken ADHD medication before. It also studies how these treatments affect brain “reward” processes, which may be linked to substance-use risk.
New York, New YorkAges 7–12 - NCT03935646RecruitingPhase 2
Test of Adderall’s short-term effects in college students with ADHD
This study measures how stimulant medication (Adderall) affects college students with ADHD in the short term. It compares people with ADHD to students without ADHD to see what changes you may notice during the study.
Laramie, WyomingAges 18–29 - NCT04144439RecruitingPhase 4
GABA treatment for ADHD and seizures in children with epilepsy
This trial studies whether adding GABA (a substance that affects brain signaling) can help children who have both epilepsy (seizures) and ADHD. If it works, it may reduce symptoms related to either seizures, ADHD, or both.
TantaAges 4–18 - NCT04532190Recruiting
Testing options beyond standard ADHD treatment
This study looks for alternatives to standard treatment for attention-deficit/hyperactivity disorder (ADHD). It may help by testing a different approach for people who meet specific age, language, and health requirements.
Calgary, AlbertaAges 9–15 - NCT04610697Recruiting
Cognitive training for people in forensic mental health care
This trial studies whether a structured “cognitive remediation” program (training thinking skills) can help people receiving care on a forensic treatment unit. It may benefit those who want support improving attention, memory, or problem-solving as part of their treatment.
Ottawa, OntarioAges 18–55 - NCT04704687RecruitingPhase 3
tDCS brain stimulation for children with ADHD symptoms
This Phase 3 study tests whether a non-painful brain stimulation method called tDCS can improve ADHD symptoms in children, and whether it helps over the long term. Your child may be able to join if they are 7–14 with a confirmed ADHD diagnosis and meet symptom and testing scores.
AmiensAges 7–14 - NCT04781140RecruitingPhase 4
Viloxazine trial for preschool kids with ADHD
This study tests whether viloxazine extended-release can reduce ADHD symptoms in children ages 4–5. It also checks safety in preschool-age kids, including heart and nervous-system side effects.
Saraland, AlabamaAges 4 years–5.8 years - NCT04946253Recruiting
Help in teams to improve care for kids with behavior problems
This study tests a program to help pediatric practice teams work together better, led by clinic leadership and managers, to support children’s behavioral health. Caregivers of children ages 5–12 with behavior problems may also be involved to connect care at home and in the clinic.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05354232Recruiting
Home electrical brain stimulation for ADHD symptoms
This study tests whether home-based low-level electrical stimulation of the brain (tDCS) can reduce attention-deficit/hyperactivity disorder (ADHD) symptoms. If you qualify, you may be asked to complete assessments while receiving the treatment.
Charlestown, MassachusettsAges 18–65 - NCT05608434RecruitingPhase 1/Phase 2
VR training for improving attention in kids with ADHD
This study tests a virtual reality (VR) program meant to strengthen attention skills in children with ADHD. It compares different VR-based training options and looks at whether kids improve on attention-related thinking skills after the sessions.
Bethesda, MarylandAges 8–16 - NCT05751525Recruiting
Oral sulfonylurea study for children with KCNJ11-related delay and epilepsy
This study looks at whether switching to an oral sulfonylurea medicine can improve thinking, development, and seizure-related outcomes in children with a specific KCNJ11 gene change. You may be able to join if your child already has this mutation and has been able to take the medicine by mouth.
Chicago, IllinoisAges 2–50 - NCT05957055RecruitingPhase 2
ADHD medicine compared for kids with type 1 diabetes
This Phase 2 study compares two ADHD medicines—lisdexamfetamine and methylphenidate—in children who have ADHD and type 1 diabetes. It’s designed to see which option works better and is safe/effective for managing ADHD without causing major problems for diabetes care.
Lodz, Łódź VoivodeshipAges 8 years–16.5 years
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for adhd?
- Yes. Clin2 currently lists 151 recruiting adhd studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a adhd trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a adhd trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.